Apellis Pharmaceuticals Inc (APLS)
27.98
+0.72
(+2.64%)
USD |
NASDAQ |
Nov 01, 16:00
27.97
-0.01
(-0.04%)
After-Hours: 20:00
Apellis Pharmaceuticals Total Assets (Quarterly): 904.48M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 904.48M |
| March 31, 2024 | 831.93M |
| December 31, 2023 | 788.73M |
| September 30, 2023 | 818.22M |
| June 30, 2023 | 915.58M |
| March 31, 2023 | 978.87M |
| December 31, 2022 | 760.22M |
| September 30, 2022 | 872.89M |
| June 30, 2022 | 1.002B |
| March 31, 2022 | 1.146B |
| December 31, 2021 | 881.76M |
| September 30, 2021 | 525.69M |
| June 30, 2021 | 699.91M |
| March 31, 2021 | 810.13M |
| December 31, 2020 | 960.57M |
| September 30, 2020 | 768.33M |
| June 30, 2020 | 870.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 688.94M |
| December 31, 2019 | 389.24M |
| September 30, 2019 | 466.36M |
| June 30, 2019 | 316.70M |
| March 31, 2019 | 318.35M |
| December 31, 2018 | 203.53M |
| September 30, 2018 | 239.15M |
| June 30, 2018 | 266.82M |
| March 31, 2018 | 163.20M |
| December 31, 2017 | 182.13M |
| September 30, 2017 | 19.14M |
| June 30, 2017 | 56.69M |
| December 31, 2016 | 27.43M |
| December 31, 2015 | 38.18M |
| September 30, 2015 | 13.74M |
| June 30, 2015 | 16.82M |
| December 31, 2014 | 14.31M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
389.24M
Minimum
Dec 2019
1.146B
Maximum
Mar 2022
821.79M
Average
831.93M
Median
Mar 2024
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.851B |
| Ionis Pharmaceuticals Inc | 2.691B |
| EyePoint Pharmaceuticals Inc | 324.25M |
| Cassava Sciences Inc | 243.57M |
| Macrogenics Inc | 201.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 640.16M |
| Shareholders Equity (Quarterly) | 264.33M |
| Debt to Equity Ratio | 1.730 |
| Current Ratio | 5.084 |
| Net Debt Paydown Yield | -1.56% |